DrugPatentWatch Database Preview
Ciprofloxacin - Generic Drug Details
What are the generic sources for ciprofloxacin and what is the scope of ciprofloxacin patent protection?
Ciprofloxacin
is the generic ingredient in sixteen branded drugs marketed by Bayer Hlthcare, Lupin Ltd, Otonomy Inc, Bayer Pharms, Baxter Hlthcare Corp, Bedford Labs, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Teva Pharms Usa, Baxter Hlthcare, Bedford, Inforlife, Teva Pharms, Novartis Pharms Corp, Akorn Inc, Altaire Pharms Inc, Amring Pharms, Anda Repository, Apotex Inc, Fdc Ltd, Teligent, Watson Labs Inc, Wraser Pharms, Depomed Inc, Ani Pharms Inc, Apotex, Aurobindo Pharma, Barr, Carlsbad, Dr Reddys Labs Ltd, Fosun Pharma, Hikma, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sun Pharm Inds Ltd, Taro Pharm, Teva, Unique Pharm Labs, Watson Labs, Yiling Pharm Ltd, Laboratorios Salvat, Actavis Labs Fl Inc, Anchen Pharms, and Mylan Pharms Inc, and is included in sixty-three NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Ciprofloxacin has one hundred and twenty-eight patent family members in nineteen countries.
There are thirty-one drug master file entries for ciprofloxacin. Ten suppliers are listed for this compound. There are five tentative approvals for this compound.
Summary for ciprofloxacin
| International Patents: | 128 |
| US Patents: | 15 |
| Tradenames: | 16 |
| Applicants: | 47 |
| NDAs: | 63 |
| Drug Master File Entries: | 31 |
| Suppliers / Packagers: | 10 |
| Bulk Api Vendors: | 90 |
| Clinical Trials: | 200 |
| Patent Applications: | 6,888 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ciprofloxacin |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ciprofloxacin |
| DailyMed Link: | ciprofloxacin at DailyMed |
Pharmacology for ciprofloxacin
| Drug Class | Quinolone Antimicrobial |
Medical Subject Heading (MeSH) Categories for ciprofloxacin
Synonyms for ciprofloxacin
| 1-Cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-[1-piperazinyl)-quinoline-3-carboxylic Acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinoline-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline -3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1piperazinyl)-3quinolinecarboxylic acid |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid |
| 1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid |
| 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid |
| 1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID |
| 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid |
| 1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid |
| 1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid |
| 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- |
| 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride |
| 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)- |
| 3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl) |
| 3-Quinolinecarboxylicacid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- |
| 5E8K9I0O4U |
| 721C331 |
| 85721-33-1 |
| A-8526 |
| AB0011928 |
| AB1009412 |
| AC-7613 |
| AC1L1EEW |
| AJ-08409 |
| AK163192 |
| AKOS000269653 |
| ALBB-015909 |
| Alcon Cilox |
| AN-8829 |
| ARONIS020379 |
| AuriPro |
| AuriPro? |
| Bacquinor |
| Baflox |
| BAS 06989041 |
| Bay 09867 |
| Bay o 9867 |
| Bay o 9867 (*Hydrochloride*) |
| BAY q 3939 |
| Bay-09867 |
| BAY-o 9867 |
| BAY-Q-3939 |
| Baycip |
| BAYQ3939 |
| BBL005612 |
| BC203729 |
| BDBM21690 |
| Bernoflox |
| Bi-Cipro |
| BIDD:GT0205 |
| Bio-0540 |
| BPBio1_000140 |
| BRD-K04804440-311-02-3 |
| BRN 3568352 |
| BSPBio_000126 |
| BSPBio_003344 |
| C05349 |
| C17H18FN3O3 |
| CAS-93107-08-5 |
| CBMicro_048498 |
| CCG-39345 |
| CCRIS 5241 |
| Cetraxal |
| CHEBI:100241 |
| CHEMBL8 |
| Ciflox |
| Cifloxin |
| Cilab |
| Ciloxan |
| Ciloxan (*Hydrochloride*) |
| Ciplus |
| Ciprecu |
| Ciprine |
| Ciprinol |
| Cipro |
| Cipro (*Hydrochloride*) |
| Cipro (TN) |
| Cipro I.V. |
| CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER |
| CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Cipro IV |
| Cipro XL |
| Cipro XR |
| Ciprobay |
| Ciprobay Uro |
| Ciprocinol |
| Ciprodar |
| Ciproflox |
| ciprofloxacillin |
| Ciprofloxacin (Cipro) |
| Ciprofloxacin (JP17/USP/INN) |
| Ciprofloxacin [USAN:INN:BAN] |
| Ciprofloxacin [USAN:USP:INN:BAN] |
| Ciprofloxacin dihydrochloride |
| CIPROFLOXACIN EXTENDED RELEASE |
| Ciprofloxacin Hydrchloride |
| Ciprofloxacin In Dextrose 5% |
| Ciprofloxacin In Dextrose 5% In Plastic Container |
| Ciprofloxacin intratympanic - Otonomy |
| Ciprofloxacin monohydrochloride |
| Ciprofloxacin, >=98.0% (HPLC) |
| Ciprofloxacin, Antibiotic for Culture Media Use Only |
| Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard |
| Ciprofloxacin, pharmaceutical secondary standard; traceable to USP and PhEur |
| Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard |
| Ciprofloxacin, VETRANAL(TM), analytical standard |
| Ciprofloxacina |
| Ciprofloxacine |
| Ciprofloxacine [INN-French] |
| Ciprofloxacino |
| Ciprofloxacino [INN-Spanish] |
| Ciprofloxacinum |
| Ciprofloxacinum [INN-Latin] |
| Ciprogis |
| Ciprolin |
| Ciprolon |
| Cipromycin |
| Ciproquinol |
| Ciprowin |
| Ciproxan |
| Ciproxin |
| Ciproxina |
| Ciproxine |
| Ciriax |
| Citopcin |
| Cixan |
| Corsacin |
| CPD000471901 |
| CPF |
| CPFX |
| CS-2410 |
| CTK3E8144 |
| Cycin |
| Cyprobay |
| D00186 |
| D03IHU |
| D0JW1A |
| DB00537 |
| DivK1c_000095 |
| DR001566 |
| DTXSID8022824 |
| Eni |
| Fimoflox |
| Flociprin |
| FT-0601635 |
| HE397506 |
| HMS1922E18 |
| HMS2090O07 |
| HMS2093I03 |
| HMS500E17 |
| HSDB 6987 |
| HY-B0356 |
| IDI1_000095 |
| Ipiflox |
| Italnik |
| J10137 |
| KB-117181 |
| KB-152640 |
| KBio1_000095 |
| KBio2_000642 |
| KBio2_003210 |
| KBio2_005778 |
| KBio3_002846 |
| KBioGR_001567 |
| KBioSS_000642 |
| KS-000002BQ |
| KS-00004C43 |
| KS-5006 |
| Linhaliq |
| Linhaliq [Liposomal Formulation] |
| Loxan |
| LS-141563 |
| MCULE-8631780654 |
| MFCD00185755 |
| MLS001336035 |
| MLS006011837 |
| MolPort-000-819-654 |
| MYSWGUAQZAJSOK-UHFFFAOYSA-N |
| NCGC00016959-01 |
| NCGC00016959-02 |
| NCGC00016959-03 |
| NCGC00016959-04 |
| NCGC00016959-05 |
| NCGC00016959-07 |
| NCGC00095058-01 |
| NCGC00095058-02 |
| NCGC00178128-01 |
| NINDS_000095 |
| NSC-758467 |
| NSC620634 |
| NSC758467 |
| Oprea1_008239 |
| Oprea1_313572 |
| Otiprio |
| OTO-201 |
| Pharmakon1600-01503614 |
| Prestwick0_000113 |
| Prestwick1_000113 |
| Prestwick2_000113 |
| Prestwick3_000113 |
| Probiox |
| Proflaxin |
| Proksi 250 |
| Proksi 500 |
| Quinolid |
| Quintor |
| Rancif |
| Roxytal |
| s2027 |
| SAM002264604 |
| SBB012554 |
| SBI-0048462.P003 |
| SC-17889 |
| SCHEMBL2900 |
| Septicide |
| SMP1_000125 |
| SMR000471901 |
| Sophixin Ofteno |
| SPBio_001474 |
| SPBio_002065 |
| Spectrum_000162 |
| SPECTRUM1503614 |
| Spectrum2_001567 |
| Spectrum3_001872 |
| Spectrum4_000874 |
| Spectrum5_001089 |
| Spitacin |
| SR-05000001863 |
| SR-05000001863-3 |
| ST024751 |
| ST24046329 |
| STK021082 |
| Superocin |
| TX-017484 |
| Unex |
| UNII-5E8K9I0O4U |
| Velmonit |
| Velomonit |
| Z56933707 |
| ZINC20220 |
| Zumaflox |
US Patents and Regulatory Information for ciprofloxacin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | CIPRO | ciprofloxacin | INJECTABLE;INJECTION | 019847-001 | Dec 26, 1990 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Dr Reddys Labs Ltd | CIPROFLOXACIN EXTENDED RELEASE | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077701-001 | Mar 26, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Hikma | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076558-004 | Jun 9, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Ivax Sub Teva Pharms | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076089-002 | Jun 9, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Apotex | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076896-003 | Nov 4, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Bayer Pharms | CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 019858-001 | Dec 26, 1990 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for ciprofloxacin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Pharms | CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 019858-001 | Dec 26, 1990 | ➤ Sign Up | ➤ Sign Up |
| Bayer Hlthcare | CIPRO | ciprofloxacin | INJECTABLE;INJECTION | 019847-001 | Dec 26, 1990 | ➤ Sign Up | ➤ Sign Up |
| Bayer Pharms | CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 019858-001 | Dec 26, 1990 | ➤ Sign Up | ➤ Sign Up |
| Bayer Hlthcare | CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 019857-001 | Dec 26, 1990 | ➤ Sign Up | ➤ Sign Up |
| Bayer Hlthcare | CIPRO | ciprofloxacin | FOR SUSPENSION;ORAL | 020780-001 | Sep 26, 1997 | ➤ Sign Up | ➤ Sign Up |
| Bayer Hlthcare | CIPRO | ciprofloxacin | INJECTABLE;INJECTION | 019847-001 | Dec 26, 1990 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for ciprofloxacin
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2009274229 | ➤ Sign Up |
| Uruguay | 31779 | ➤ Sign Up |
| Japan | 2015164943 | ➤ Sign Up |
| Japan | 2016026218 | ➤ Sign Up |
| Hong Kong | 1209055 | ➤ Sign Up |
| Canada | 2721927 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for ciprofloxacin
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB12/058 | United Kingdom | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
| C0012 | France | ➤ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: